The approval for a U.S. start-up’s “cultured chicken” product is a small victory for the nascent laboratory meat industry. Less clear is whether other countries will follow Singapore’s lead.
Researchers at DeepMind say they have solved “the protein folding problem,” a task that has bedeviled scientists for more than 50 years.
As the outbreak surges around the country, the testing delays show the basic public health challenges that the country still faces.
Several scientists working with harmless genetic material have discovered that their research may have contaminated their coronavirus tests.
A head-to-head comparison of lab and rapid coronavirus tests drew mixed reactions from experts, who raised concerns about accuracy.
With state and city government support, developers are building laboratories for medical research and incubator spaces for biotech start-ups amid the race for a coronavirus vaccine.
Labs closed in the pandemic, but innovation doesn’t stop. So while some workers have the home office, engineers have the garage.
Two tests made by Quidel and BD repeatedly delivered false-positive results, prompting the state to stop using them.
Some conservationists accepted the explanation provided by Botswana’s government, but others raised doubts.
Intermediaries are finding labs with capacity for companies seeking to make sure workers are virus-free. But many employers choose to avoid the cost.
The buzzy idea is impractical, critics said. And there isn’t yet real-world data to show it will work.
The New York-based scientist overcame sexism and personal tragedy to make major contributions to the field, for which she received recognition this year.
Standard tests in New York City can take days or weeks. Wealthier people are turning to concierge services and small laboratories to get results in as little as 24 hours.
The usual diagnostic tests may simply be too sensitive and too slow to contain the spread of the virus.
The chip maker was selected for an Energy Department project meant to show American tech independence. But problems at Intel have thrown a wrench into the effort.
Our readers sent in smart questions about this thorny issue.
Inspired by a mother’s question, the new method will be introduced across Israel this fall, just in time for flu season, and could be coming soon to the U.S.
Experts are revising their views on the best methods to detect infections, setting aside long-held standards so that the spread of the virus can be more quickly tracked and contained.
The country’s capacity to make testing efficient, affordable and available has distinguished it. Now, to head off a potential second wave, it’s testing anyone returning from a “hot zone” on entry.
With the reopening plans of schools and businesses hinging on rapid test results, the Trump administration’s testing czar says a two- to three-day turnaround “is not possible.”
States should look to New York’s strategies.
Bioprinting could be used for testing potential treatments for Covid-19, cancer and other diseases.
If it takes 12 days to get results, it’s basically pointless.
Just weeks after resolving shortages in swabs, researchers are struggling to find the chemicals and plastic pieces they need to carry out coronavirus tests in the lab — leading to long waiting times.
Public health experts say delays in testing continue to hinder attempts to track and contain the spread of disease.
Before public health officials can manage the pandemic, they must deal with a broken data system that sends incomplete results in formats they can’t easily use.
Dr. Daniel R. Lucey wants answers to pointed questions that bear on how the coronavirus leapt from bats to humans.
Millions of additional coronavirus tests may be processed with “pooling,” enabling widespread surveillance as the country struggles to reopen.
The Louisiana case highlights how prosecutors and crime labs withhold key documents from defense lawyers, keeping some defendants in custody for months or years.
The fragmented U.S. health care system has hampered efforts to expand coronavirus testing, by making it difficult for hospitals to switch to new labs with ample capacity.
The British government promised 100,000 daily tests by April 30. It delivered. But the frantic push to hit that deadline has left labs scrabbling for supplies just when they need to expand further.
The OpenAg project, which promised crops that could be grown in thin air, faced scrutiny at the same time that Jeffrey Epstein’s financial ties to the M.I.T. Media Lab came to light.
In just three months, international researchers working together found 30 already existing drugs that seem to stop the coronavirus from destroying human cells.
Henry Gindt II, 34, shipped stolen test kits to several customers, who never received the results despite spending as much as $200 per test, the authorities said.
New findings, scientists say, will speed up the mass production of affordable self-collection kits that can be dropped in the mail.
Is Beijing keeping a secret? Or are the exact origins of the coronavirus still a mystery?
A rural lab has a 120-year history of fighting mysterious diseases.
The secretary of state cited “enormous evidence” that the virus came from a research laboratory in Wuhan, backing an assertion by President Trump.
In short supply, the samples are vital for the creation of coronavirus antibody tests that can help end lockdowns. Several companies are racing to capitalize on that.
The project, announced by the C.D.C., will help trace patterns of transmission, investigate outbreaks and map how the virus is evolving, which can impact a cure.
Some analysts are worried that the pressure from senior officials could distort assessments about the coronavirus and be used as a weapon in an escalating battle with China.
As scientists at the Jenner Institute prepare for mass clinical trials, new tests show their vaccine to be effective in monkeys.
One that mobilizes scientists.
The good news is that the pandemic shows “science works.” The bad news? Global warming may be far more dangerous than a pandemic.
Coronavirus has prompted many scientists to make space in their homes for their lab animals.
Fallout from the agency’s failed rollout of national coronavirus kits two months ago continues to haunt U.S. efforts to combat the spread of the highly infectious virus.
Facing a global scramble for materials, British officials bought millions of unproven kits from China in a gamble that became an embarrassment.
Flawed tests, scarce supplies and limited access to screening have hurt the U.S.’s ability to monitor Covid-19, governors and health officials warn.
The backlog for Covid-19 testing in New Jersey and other parts of the country is getting worse, not better. From the nose of a patient on a mile-long line to a phone call days later, bottlenecks thwart its progress.
Developing nations in Latin America and Africa cannot find enough materials and equipment to test for coronavirus, partly because the United States and Europe are outspending them.